Document 57 - Amendment to the Act on Medical Devices and In Vitro Diagnostic Medical Devices - EU - RJ
Summary
The amendment introduces a new system for mandatory reporting of interruptions or discontinuations in the supply of medical devices by manufacturers, distributors, and healthcare providers, to be done electronically via the Medical Devices Information System. The Institute gains significantly broader powers to investigate the unavailability of devices and can request data from all parts of the supply chain. The Ministry of Health is newly granted the authority to issue rapid general measures, allowing it to temporarily regulate the introduction, distribution, prescription, or use of devices in the event of an impending or actual shortage. Penalties for failing to meet these reporting obligations or violating the conditions set by the measures are significantly tightened, with fines reaching up to CZK 15 million.
The aim of these changes is to enable timely responses to potential shortages of devices and to ensure the availability of healthcare in accordance with new European regulations.